Companies / Signadori Bio
Signadori Bio
Paris, France
Signadori Bio develops next-generation in vivo monocyte immunotherapy to treat solid tumors.
Signadori Bio, based in Paris, France, has 2 investors on file, among them Sofinnova Partners and Taiho Ventures. Its latest round on record is Seed, 6 May 2026. Its site was last checked 12 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Page + round | Venture capital | |
| Portfolio page | Corporate VC |
More from Sofinnova Partners
111 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (69%), AI & Machine Learning (13%), Food & Agriculture (4%).
See Sofinnova Partners' full profile · Who invests alongside it
More from Taiho Ventures
23 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Signadori Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Sofinnova Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/signadoribio.com/investors
# also
GET /v1/companies/signadoribio.com
GET /v1/companies/signadoribio.com/news